# Vivax Elimination With Tafenoquine (VET) Study

> **NCT06575647** · PHASE4 · COMPLETED · sponsor: **Shoklo Malaria Research Unit** · enrollment: 1242 (actual)

## Conditions studied

- Malaria
- Malaria, Vivax
- Plasmodium Vivax
- Plasmodium Vivax Malaria

## Interventions

- **DRUG:** Tafenoquine

## Key facts

- **NCT ID:** NCT06575647
- **Lead sponsor:** Shoklo Malaria Research Unit
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-19
- **Primary completion:** 2025-10-04
- **Final completion:** 2025-10-04
- **Target enrollment:** 1242 (ACTUAL)
- **Last updated:** 2026-01-06

## Collaborators

- Mahidol Oxford Tropical Medicine Research Unit

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06575647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06575647, "Vivax Elimination With Tafenoquine (VET) Study". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06575647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*